xBind demonstrates accurate prediction of protein binding sites in various interactions, suggesting enhanced capabilities for molecular interactions.
xBind is an interactive, freely accessible, and fully configurable webserver for large language model (LLM)-enabled cross-molecular protein binding-site prediction. xBind leverages LLM embeddings from the ESM-2 model together with sequence- and structure-derived features to predict protein-protein, protein-DNA, and protein-RNA binding sites using symmetry-aware deep graph neural networks. The input to xBind is either a single-chain protein sequence in FASTA format or a monomer protein structure in PDB or mmCIF format and it outputs predicted residue-level binding sites of the input protein with its pre-selected interaction partner. The customizable xBind web interface provides: (i) choice of interaction partners including protein-protein, protein-DNA, and protein-RNA; (ii) on-the-fly AlphaFold-based protein structure prediction for sequence-only inputs; (iii) on-demand selection of the likelihood threshold for calibrating structure-aware binding site annotations; (iv) interactive and interpretable web-based results, including sequence and structural visualizations and plots of residue-level binding likelihoods with user-adjustable threshold calibration; and (v) extensive help information for usage and results interpretation through a web-based tutorial and guide. xBind is freely available at https://fusion.cs.vt.edu/xBind.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: